1 박종무, "한국 뇌졸중 진료지침에서 심방세동 환자의 뇌졸중 일차예방에 관한 내용의 부분 개정" 대한뇌졸중학회 14 (14): 106-115, 2012
2 Connolly SJ, "The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE)study" 128 : 237-243, 2013
3 Jung KH, "Secular trends in ischemic stroke characteristics in a rapidly developed country:results from the Korean Stroke Registry Study (secular trends in Korean stroke)" 5 : 327-334, 2012
4 "Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group" 342 : 1255-1262, 1993
5 Patel MR, "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation" 365 : 883-891, 2011
6 Hankey GJ, "Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF" 11 : 315-322, 2012
7 "Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials" 154 : 1449-1457, 1994
8 Go AS, "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA)Study" 285 : 2370-2375, 2001
9 Ntaios G, "Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials" 43 : 3298-3304, 2012
10 Chatterjee S, "New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation" 70 : 1486-1490, 2013
1 박종무, "한국 뇌졸중 진료지침에서 심방세동 환자의 뇌졸중 일차예방에 관한 내용의 부분 개정" 대한뇌졸중학회 14 (14): 106-115, 2012
2 Connolly SJ, "The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE)study" 128 : 237-243, 2013
3 Jung KH, "Secular trends in ischemic stroke characteristics in a rapidly developed country:results from the Korean Stroke Registry Study (secular trends in Korean stroke)" 5 : 327-334, 2012
4 "Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group" 342 : 1255-1262, 1993
5 Patel MR, "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation" 365 : 883-891, 2011
6 Hankey GJ, "Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF" 11 : 315-322, 2012
7 "Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials" 154 : 1449-1457, 1994
8 Go AS, "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA)Study" 285 : 2370-2375, 2001
9 Ntaios G, "Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials" 43 : 3298-3304, 2012
10 Chatterjee S, "New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation" 70 : 1486-1490, 2013
11 Hart RG, "Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation" 146 : 857-867, 2007
12 Miller CS, "Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation" 110 : 453-460, 2012
13 Kernan WN, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association" 45 : 2160-2236, 2014
14 Dentali F, "Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature" 126 : 2381-2391, 2012
15 ACTIVE Investigators, "Effect of clopidogrel added to aspirin in patients with atrial fibrillation" 360 : 2066-2078, 2009
16 Giugliano RP, "Edoxaban versus warfarin in patients with atrial fibrillation" 369 : 2093-2104, 2013
17 Hori M, "Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation" 44 : 1891-1896, 2013
18 Connolly SJ, "Dabigatran versus warfarin in patients with atrial fibrillation" 361 : 1139-1151, 2009
19 Diener HC, "Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial" 9 : 1157-1163, 2010
20 Kim BJ, "Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry" 9 : 514-518, 2014
21 Ruff CT, "Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials" 383 : 955-962, 2014
22 Granger CB, "Apixaban versus warfarin in patients with atrial fibrillation" 365 : 981-992, 2011
23 Diener HC, "Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial" 11 : 225-231, 2012
24 Connolly SJ, "Apixaban in patients with atrial fibrillation" 364 : 806-817, 2011
25 Easton JD, "Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial" 11 : 503-511, 2012
26 January CT, "2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society" 130 : e199-e267, 2014
27 Camm AJ, "2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association" 33 : 2719-2747, 2012